Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Market Chatter: Swiss Life to Bid for German Biotech-Focused Industrial Park

07/22/2021 | 11:26pm EDT


© MT Newswires 2021
All news about BIONTECH SE
02:29pHealth Care Slips Amid Defensive Bias - Health Care Roundup
DJ
01:16pBIONTECH : Pfizer, BioNTech Submits Data to FDA on Phase 2/3 Trial of COVID-19 Vaccine in ..
MT
11:11aEuropean ADRs Decline in Tuesday Trading
MT
09:19aPFIZER : BioNTech Report Successful COVID-19 Vaccine Trial Results In Children Under 12
MT
09:05aWALL STREET STOCK EXCHANGE : Is inflation still transitionary?
08:13aSanofi ditches mRNA COVID-19 vaccine after rivals' success
RE
08:11aPFIZER : MHRA - Regulatory approval of Pfizer/BioNTech vaccine for COVID-19
AQ
07:45aPFIZER : BioNTech Submits Data to FDA on Phase 2/3 Trial of COVID-19 Vaccine in Children
MT
07:32aBIONTECH : PFIZER AND BIONTECH SUBMIT INITIAL DATA TO U.S. FDA FROM PIVOTAL TRIAL OF COVID..
PU
07:03aMODERNA : Pfizer submits data for COVID-19 vaccine use in younger kids
RE
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 16 863 M 19 702 M 19 702 M
Net income 2021 8 881 M 10 376 M 10 376 M
Net cash 2021 9 100 M 10 632 M 10 632 M
P/E ratio 2021 6,67x
Yield 2021 -
Capitalization 57 155 M 66 785 M 66 780 M
EV / Sales 2021 2,85x
EV / Sales 2022 2,13x
Nbr of Employees 2 500
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 236,65 €
Average target price 279,55 €
Spread / Average Target 18,1%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE239.21%74 169
GILEAD SCIENCES, INC.20.10%88 281
WUXI APPTEC CO., LTD.34.48%69 209
REGENERON PHARMACEUTICALS25.23%64 363
VERTEX PHARMACEUTICALS-23.16%47 582
BEIGENE, LTD.40.79%35 092